A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction of Clinical Response and Remission by Vedolizumab in Patients With Moderate to Severe Crohn's Disease
收藏DataCite Commons2026-03-02 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00002524/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
This study in patients with moderately to severely active Crohn's disease is designed to establish the efficacy and safety of vedolizumab for the induction of clinical response and remission.
提供机构：
Vivli
创建时间：
2018-10-27
